Healthcare was the largest of STERIS plc’s 3 reported lines in fiscal 2026, at $1.50B — 46% of $3.22B.
| Segment | FY 2017 | FY 2018 | FY 2019 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|
| Healthcare | $1.05B | $1.27B | $1.45B | $1.50B | |||
| Ast | $914.43M | $939.50M | $1.01B | $1.14B | |||
| Applied Sterilization Technologies | — | — | — | — | |||
| Healthcare Products | — | — | — | — | |||
| Healthcare Specialty Services | — | — | — | — | |||
| Life Sciences | $536.70M | $251.60M | $286.70M | $588.80M | |||
| Life Science | — | — | — | — | |||
| Total | $2.50B | $2.46B | $2.74B | $3.22B |
In fiscal 2026, which ended March 31, 2026, the 3 segments STERIS plc reported in this breakdown added up to $3.22B. That is less than the $5.94B in its breakdown by region, so these segments do not account for all of its revenue that year. Healthcare was the largest segment, at $1.50B or 46.4% of the total, followed by Ast ($1.14B, 35.3%) and Life Sciences ($588.80M, 18.3%). Together, the two largest segments made up 81.7% of this total.
Compared with fiscal 2025, Life Sciences grew the fastest, rising 105.4% to $588.80M. Every sizeable segment reported in both years grew.
The table also keeps 4 segments that STERIS plc no longer reports, so earlier years can still be read on their original basis; use "Show 4 discontinued" beneath the table to see them. This breakdown covers 7 fiscal years between 2017 and 2026, as reported in STERIS plc's annual filings.
Service was the largest of STERIS plc’s 3 reported lines in fiscal 2026, at $1.62B — 38% of $4.21B.
| Product and Service | FY 2017 | FY 2017 | FY 2017 | FY 2018 | FY 2018 | FY 2018 | FY 2018 | FY 2019 | FY 2019 | FY 2019 | FY 2019 | FY 2020 | FY 2020 | FY 2020 | FY 2020 | FY 2021 | FY 2021 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $1.14B | $1.27B | $1.45B | $1.62B | ||||||||||||||||||||
| Service Revenues | — | — | — | — | ||||||||||||||||||||
| Capital Equipment | $896.59M | $1.09B | $1.04B | $1.10B | ||||||||||||||||||||
| Capital Equipment Revenues | — | — | — | — | ||||||||||||||||||||
| Consumables | $241.11M | $1.25B | $1.40B | $1.50B | ||||||||||||||||||||
| Consumable Revenues | — | — | — | — | ||||||||||||||||||||
| Product | $2.36B | — | — | — | ||||||||||||||||||||
| Total | $4.64B | $3.61B | $3.88B | $4.21B |
In fiscal 2026, which ended March 31, 2026, the 3 revenue lines STERIS plc reported in this breakdown added up to $4.21B. That is less than the $5.94B in its breakdown by region, so these revenue lines do not account for all of its revenue that year. Service was the largest revenue line, at $1.62B or 38.4% of the total, followed by Consumables ($1.50B, 35.6%) and Capital Equipment ($1.10B, 26.0%). Together, the two largest revenue lines made up 74.0% of this total.
Compared with fiscal 2025, Service grew the fastest, rising 11.8% to $1.62B. Every sizeable revenue line reported in both years grew.
The table also keeps 4 revenue lines that STERIS plc no longer reports, so earlier years can still be read on their original basis; use "Show 4 discontinued" beneath the table to see them. This breakdown covers 24 fiscal years between 2017 and 2026, as reported in STERIS plc's annual filings.
United States was the largest of STERIS plc’s 3 reported lines in fiscal 2026, at $4.33B — 73% of $5.94B.
| Geography | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|
| United States | $3.75B | $4.01B | $4.33B | |||||
| Other Foreign Locations | $1.30B | $1.34B | $1.49B | |||||
| Ireland | $82.70M | $107.30M | $108.50M | |||||
| United Kingdom | — | — | — | |||||
| Total | $5.14B | $5.46B | $5.94B |
In fiscal 2026, which ended March 31, 2026, the 3 regions STERIS plc reported in this breakdown added up to $5.94B. That was up 8.7% from $5.46B in fiscal 2025. United States was the largest region, at $4.33B or 73.0% of the total, followed by Other Foreign Locations ($1.49B, 25.2%) and Ireland ($108.50M, 1.8%). Together, the two largest regions made up 98.2% of this total.
Compared with fiscal 2025, Other Foreign Locations grew the fastest, rising 11.1% to $1.49B. Over fiscal 2024 to 2026, revenue across these regions went from $5.14B to $5.94B, a compound annual growth rate of 7.5%. United States held a steady share of about 73.0%.
The table also keeps 1 region that STERIS plc no longer reports, so earlier years can still be read on their original basis; use "Show 1 discontinued" beneath the table to see them. This breakdown covers 8 fiscal years between 2017 and 2026, as reported in STERIS plc's annual filings.
STERIS plc (STE) breaks its revenue down by segment, revenue line and region. In fiscal 2026, its largest segment was Healthcare, with $1.50B or 46.4% of the total, followed by Ast at $1.14B (35.3%).
Healthcare was STERIS plc's largest segment in fiscal 2026, with $1.50B in revenue, 46.4% of the $3.22B reported across its 3 segments.
Service was STERIS plc's largest revenue line in fiscal 2026, with $1.62B in revenue, 38.4% of the $4.21B reported across its 3 revenue lines.
United States was STERIS plc's largest region in fiscal 2026, with $4.33B in revenue, 73.0% of the $5.94B reported across its 3 regions.
Of the STERIS plc segments reported in both fiscal 2025 and fiscal 2026, and making up at least 2% of the total, Life Sciences grew the fastest, rising 105.4% from $286.70M to $588.80M.
Every figure is taken from STERIS plc's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2017 to 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.